Johnson & Johnson receives $115 million to accelerate Ebola vaccine development

January 16, 2015 9:30 PM

6 0

Johnson & Johnson receives $115 million to accelerate Ebola vaccine development

Johnson & Johnson receive 100 million euros to accelerate the development of their Ebola vaccine.

Johnson & Johnson will receive 100 million euros, approximately $115 million, to support the development of their Ebola vaccine, the company announced Friday.

Read more

To category page

Loading...